hotspot -WSS

hotspot

author：fashion 2025-09-06 06:17:06 - browse：7

Duchenne muscular dystrophy Histopathology — Duchenne muscular dystrophy histopathology. Dr. Edwin P. Ewing, Jr./CDC

Japanese drugmaker Nippon Shinyaku said on Monday that its Duchenne muscular dystrophy drug, Viltepso, part of a controversial class of treatments for the rare disease, had failed to reach its primary endpoint in a placebo-controlled confirmatory trial.

Children who received the drug could stand up faster from the floor at the end of the study, but so could children who received a placebo. There was no statistically significant difference between the groups.

Although Nippon did not release detailed data, the failure is notable because Viltepso belongs to a contentious class of drugs called exon-skippers. Duchenne is caused by mutations in a muscle-supporting gene called dystrophin. These drugs are designed to increase the amount of dystrophin protein that patients with specific mutations produce. But the drugs only lead to slight increases in protein levels, and their clinical benefits have never been proven in a large, placebo-controlled study.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Nonprofit, backed by Microsoft, to certify AI tools in health care

focus

WSS

Profiling embryos to choose those with higher IQs is almost a reality

Life science postdocs should get big pay hike, NIH panel says

JPM pitch from hospitals? Revenue streams outside of patient care

Doctors in states that ban abortion can still help patients

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Snowpack in the West is melting rapidly. Where will all that extra water go?

leisure time

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Cancer drug shortages should be causing more outrage

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Guidelines to prevent youth baseball injuries need more muscle

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Medical records are filled with copy

Life science postdocs should get big pay hike, NIH panel says

At least 13 dead in Texas as scorching temps continue

American taxpayers paid $1.8 trillion in health care costs in 2022

Cancer drug shortages should be causing more outrage

Does Paxlovid work in people vaccinated against Covid

entertainment

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Ascension's ugly legal battle over care for poor patients in Texas

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

HCA says smaller share of spending going to labor

HCA says smaller share of spending going to labor

Doctors increasingly discourage vaping amid mounting health concerns

Wikipedia

focus

focus

focus